DIA
Drug Information Association Logo

Advanced Search

Search Poster Presentations

Search Poster Presentation 

Poster Number Poster Title Poster Type Date/Time Poster Presenter
1 The Implementation of Global Access Licensing Policies by European and North American Universities Student Tue, Mar 05 8:30AM Alan Abraham
10 Synthesis, chemical and biological characterization of 21-ester of fluocinolone acetonide with 2-isoxypropanoic acid Student Tue, Mar 05 8:30AM Natalija Peric
11 A review of indexing used in MEDLINE and EMBASE as means of facilitating the identification of adverse drug reactions. Professional Tue, Mar 05 8:30AM Laura Mulligan
11 Preparation and evaluation of chitosan microspheres used for increasing permeability of urinary bladder wall Student Tue, Mar 05 8:30AM Ana Preglav
12 A checklist to assess the impact of the European Regulation n°1901/2006 on paediatric protocols quality Student Tue, Mar 05 8:30AM Audrey Robin
12 Evaluation of medication errors in pediatric patients with respiratory diseases: a community pharmacy-based study Professional Tue, Mar 05 8:30AM Sinziana Ioana Oncioiu
13 Assessment of the Non-Therapeutic Factors Impact on the Accurancy of Clinical Parameters in Clinical Trials Professional Tue, Mar 05 8:30AM Kseniia Ratushna
13 Assessment of Disease Activity in Patients of Rheumatoid Arthritis on Disease Modifying Anti-Rheumatic Drugs (DMARDs). Student Tue, Mar 05 8:30AM Aditi Hitesh Shah
14 Motherwort's extract effects on Rat Mesenteric Arterioles Student Tue, Mar 05 8:30AM Migle Skadauskaite
14 Do we measure Safety Case Reporting Compliance consistently across the EU? Professional Tue, Mar 05 8:30AM Peter Schueler
15 Development of specific antibodies by the method of Phage Display for targeting the circulating tumor cells marker E-Cadherin Student Tue, Mar 05 8:30AM Katja Srpan
15 How electronic is electronic reporting Professional Tue, Mar 05 8:30AM Anika Staack
16 Kynurenic Acid - A newly identified beneficial tea component Student Tue, Mar 05 8:30AM Monika Turska
16 Development of Experimental Nephrotoxicity Model in vivo and Assessment of Its’ Applicability for Stem Cell Research Professional Tue, Mar 05 8:30AM Egle Svitojute
17 The influence of comedication and gender on lamotrigine pharmacokinetics in pediatric patients with epilepsy Student Tue, Mar 05 8:30AM Vladimir Vujovic
17 Effective Use of Electronic Patient-Reported Outcomes (PROs) in Oncology Professional Tue, Mar 05 8:30AM Valdo Arnera
18 Comparison of Clinical Trial Application Approval Timelines of Global Studies for a Late Stage Investigational Compound Professional Tue, Mar 05 8:30AM Bridget Walton
18 Role of pharmacists in consulting patients for need of antibiotic treatment Student Tue, Mar 05 8:30AM Karolina Zigaite
19 Research Fraud and Failed Clinical Trials via Fictitious Study Participants: Is it An American or An International Problem? Professional Tue, Mar 05 8:30AM Charles Wilcox
2 Tailored therapy based on pharmacogenomic parameters: an update for blood pressure lowering drugs Student Tue, Mar 05 8:30AM Annaelle David
2 Integrating elicited patient preferences and clinical trial data in a quantitative model for benefit-risk assessment Professional Tue, Mar 05 8:30AM Henk Broekhuizen
20 Interchangeability of Gabapentin Generic Formulations in the Netherlands: a Comparative Bioavailability Study Professional Tue, Mar 05 8:30AM Yang Yu
21 Pharmacovigilance System Master File (PSMF) requirements for quality management practices. Professional Tue, Mar 05 8:30AM Steen Lindequist
3 Not all commercially available splitting devices are sufficiently accurate and precise to use in clinical practice Student Tue, Mar 05 8:30AM Myrthe Elisabeth Doeve
3 Why (not) go East? Comparison of FDA Inspections from CEE, WE and US Investigational Site Inspections Professional Tue, Mar 05 8:30AM Paul H. Caldron
4 Adverse drug reaction reporting by patients: a new European challenge? Student Tue, Mar 05 8:30AM Alice Fouretier
4 International Observational Studies: The Increased Need for a Common European Regulation Professional Tue, Mar 05 8:30AM Giovanni Fiori
5 The role of the thorough QT study in drug development: A review of centrally approved drugs in Europe (2009-2012) Professional Tue, Mar 05 8:30AM Frank Holtkamp
5 Fixed dose/ fixed ratio combinations: are current EU and US regulatory guidelines adequate? Student Tue, Mar 05 8:30AM Yvonne Gautam
6 Socioeconomic costs of heroine dependence and evaluation of methadone maintenance therapy (MMT) from social perspective. Student Tue, Mar 05 8:30AM Jaroslaw Jarzebowski
6 Applying Risk Management Plan Strategies to Project Management /Monitoring in EDC and eTMF global clinical trials Professional Tue, Mar 05 8:30AM Sherri A. Hubby
7 Enantiospecific interaction of propranolol stereoisomers with ß-cyclodextrin conjugated Ag nanoparticles probed by SERS Student Tue, Mar 05 8:30AM Raul Nicoara
8 DNA microencapsulation through external gelation Student Tue, Mar 05 8:30AM Claudia Oliveira
8 Determinants for Predicting Serious Adverse Event (SAE) Rates Across Study Duration in Selected CNS Indications. Professional Tue, Mar 05 8:30AM Weng Lee
9 Comparative analysis of spontaneous adverse drug reaction reporting forms for health care professionals in EEA countries. Professional Tue, Mar 05 8:30AM Agata Aleksandra Lazowska
9 The assessment of hepatoprotective activity of wormwood (artemisia absinthium) medicinal plant in experimental study in vivo Student Tue, Mar 05 8:30AM Renaldas Pavydis
TBD Patient Reported Outcomes (PRO) in safety adverse event reporting – a new framework Professional Tue, Mar 05 8:30AM Swapu Banerjee
© 2015 DIA